Indication
End-stage lung disease
1 clinical trial
1 product
Clinical trial
A Phase 2b Open-Label, Single Arm Study to Evaluate the Efficacy of Voxelotor for Improving Oxygen Saturation and Reducing Ventilatory Support Requirements in Adult Patients With New or Increased Oxygen RequirementStatus: Terminated, Estimated PCD: 2023-06-28
Product
Voxelotor